XML 30 R10.htm IDEA: XBRL DOCUMENT
v3.19.3

Intangible Assets, Net | 9 Months Ended
--- | ---
Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets, Net | Intangible Assets, Net At September 30, 2019, the Company’s intangible assets, net, consisted of the following:
| Useful Life (Years) |  | Gross September 30, 2019 |  | Accumulated Amortization |  | Net September 30, 2019
Indefinite lived assets: |  |  |  |  |  |  |
Medicare license | N/A |  | $ | — |  |  | $ | — |  |  | $ | — |
Amortized intangible assets: |  |  |  |  |  |  |
Network relationships | 11-15 |  | 151,152,000 |  |  | (57,503,773 | ) |  | 93,648,227 |
Management contracts | 15 |  | 22,832,000 |  |  | (9,146,391 | ) |  | 13,685,609 |
Member relationships | 12 |  | 6,696,000 |  |  | (2,086,523 | ) |  | 4,609,477 |
Patient management platform | 5 |  | 2,060,000 |  |  | (755,333 | ) |  | 1,304,667 |
Tradename/trademarks | 20 |  | 1,011,000 |  |  | (92,675 | ) |  | 918,325 |
|  |  | $ | 183,751,000 |  |  | $ | (69,584,695 | ) |  | $ | 114,166,305 |
At December 31, 2018, the Company’s intangible assets, net, consisted of the following:
| Useful Life (Years) |  | Gross December 31, 2018 |  | Accumulated Amortization |  | Net December 31, 2018
Indefinite lived assets: |  |  |  |  |  |  |
Medicare license | N/A |  | $ | 1,994,000 |  |  | $ | — |  |  | $ | 1,994,000 |
Amortized intangible assets: |  |  |  |  |  |  |
Network relationships | 11-15 |  | 109,883,000 |  |  | (48,361,773 | ) |  | 61,521,227 |
Management contracts | 15 |  | 22,832,000 |  |  | (7,447,581 | ) |  | 15,384,419 |
Member relationships | 12 |  | 6,696,000 |  |  | (1,289,667 | ) |  | 5,406,333 |
Patient management platform | 5 |  | 2,060,000 |  |  | (446,333 | ) |  | 1,613,667 |
Tradename/trademarks | 20 |  | 1,011,000 |  |  | (54,763 | ) |  | 956,237 |
|  |  | $ | 144,476,000 |  |  | $ | (57,600,117 | ) |  | $ | 86,875,883 |
Included in depreciation and amortization on the accompanying condensed consolidated statements of income is amortization expense of $4.3 million and $4.2 million (excluding $0.1 million of amortization expense for exclusivity incentives) for the three months ended September 30, 2019 and 2018, respectively, and $12.0 million and $12.8 million (excluding $0.3 million of amortization expense for exclusivity incentives) for the nine months ended September 30, 2019 and 2018, respectively. During the three and nine months ended September 30, 2019, the Company wrote off indefinite-lived intangible assets of $2.0 million related to Medicare licenses it acquired as part of the Merger. The Company will no longer utilize these licenses and as such the Company will not receive future economic benefits. Future amortization expense is estimated to be as follows for the following years ending December 31:
| Amount
2019 (excluding the nine months ended September 30, 2019) | $ | 4,212,000 |
2020 | 15,757,000 |
2021 | 14,436,000 |
2022 | 13,559,000 |
2023 | 12,341,000 |
Thereafter | 53,861,000 |
Total | $ | 114,166,000 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration